← Back to Clinical Trials
Recruiting NCT05516069

NCT05516069 Our Healthbox - Evaluating Interactive Dispensing Systems for Low-Barrier Access to HIV Testing and Harm Reduction.

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05516069
Status Recruiting
Phase
Sponsor Unity Health Toronto
Condition HIV
Study Type INTERVENTIONAL
Enrollment 5,000 participants
Start Date 2023-01-23
Primary Completion 2025-12-30

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Our Healthbox (smart vending machine or interactive dispensing system)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 5,000 participants in total. It began in 2023-01-23 with a primary completion date of 2025-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

When REACH Nexus at MAP Centre for Urban Solutions out of St. Michael's Hospital launched its signature program, I'm Ready in 2021, our goal was to democratize access to free HIV self-testing to reach the undiagnosed in Canada. The program, the first of its kind in Canada has been successfully rolling out 50,000 free, HIV self-tests and connecting participants via a mobile app on an iOS or Android smart phone to care. While this is an important milestone in improving access, REACH knows that more needs to be done. An estimated 20-30% of undiagnosed individuals do not have access to a phone to order the HIV self-tests, and many face multiple barriers to accessing healthcare and harm reduction support: chaotic life circumstances, addiction challenges, stigma and more. Everyone in Canada should have equitable access to the health care they need. But REACH knows that this is not the case.So, REACH is working hard to change this. hese ongoing barriers inspired us to continue creating innovative solutions, and launch our second signature program, Our Healthbox. Our Healthbox meets people where they are, with what they need for their health and well-being. This program is scaling up innovations in health technologies to reach undiagnosed individuals with HIV. These smart interactive vending machines will be strategically located across Canada. The goal is to reach people where they live to provide free and low barrier access to HIV self-testing kits, STBBI testing and other harm reduction supplies. Participation in Our Healthbox, as with I'm Ready, also gives us the opportunity to collect important data that will continue to inform and guide REACH Nexus' work to grow and scale innovative health solutions across the country.

Eligibility Criteria

Inclusion Criteria: * Age 16 years or older (except for Quebec: age 18 years or older) * Person living in Canada (Canadian resident) * Able to provide consent in English or French (via the machine screen) Exclusion Criteria: * Does not meet all inclusion criteria

Contact & Investigator

Central Contact

Sean B Rourke, PhD

✉ sean.rourke@utoronto.ca

📞 (416) 878-2779

Principal Investigator

Sean B Rourke, PhD

PRINCIPAL INVESTIGATOR

MAP Centre for Urban Health Solutions, St. Micheal's Hospital

Frequently Asked Questions

Who can join the NCT05516069 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, studying HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05516069 currently recruiting?

Yes, NCT05516069 is actively recruiting participants. Contact the research team at sean.rourke@utoronto.ca for enrollment information.

Where is the NCT05516069 trial being conducted?

This trial is being conducted at Moncton, Canada.

Who is sponsoring the NCT05516069 clinical trial?

NCT05516069 is sponsored by Unity Health Toronto. The principal investigator is Sean B Rourke, PhD at MAP Centre for Urban Health Solutions, St. Micheal's Hospital. The trial plans to enroll 5,000 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology